Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating satralizumab for thyroid eye disease has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Satralizumab (satralizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Thyroid Eye Disease, TED | Phase 3 | Status: COMPLETED | Results posted: 2026-07-31